Serum Leucine-Rich α 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis

J Immunol Res. 2019 Feb 4:2019:3140204. doi: 10.1155/2019/3140204. eCollection 2019.

Abstract

To investigate whether serum leucine-rich α2-glycoprotein (LRG) levels are useful as a marker of disease activity in systemic juvenile idiopathic arthritis (s-JIA), we determined serum LRG levels in fifty-nine s-JIA patients, 15 with other subtypes of JIA, 7 with Kawasaki disease (KD), 7 with influenza A infection (flu), 7 with enterohemorrhagic Escherichia coli (EHEC) infection, and 20 healthy controls (HC). Results were compared with the clinical features of s-JIA and serum cytokine levels including interleukin- (IL-) 6, IL-18, and soluble tumor necrosis factor receptors I and II. Serum LRG levels in active s-JIA were higher compared to those in other subtypes of JIA, EHEC, flu patients, and HC. Serum LRG levels were normalized in the inactive s-JIA phase after treatment. Serum LRG levels were positively correlated with serum C-reactive protein and ferritin levels. Serum LRG levels reflected s-JIA disease activity and thus may be useful for monitoring s-JIA disease activity.

MeSH terms

  • Adolescent
  • Adult
  • Arthritis, Juvenile / blood*
  • Arthritis, Juvenile / diagnosis*
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Child
  • Child, Preschool
  • Cytokines / blood
  • Female
  • Ferritins / blood
  • Glycoproteins / blood*
  • Humans
  • Infant
  • Interleukin-18 / blood
  • Interleukin-6 / blood
  • Male
  • Young Adult

Substances

  • Biomarkers
  • Cytokines
  • Glycoproteins
  • IL18 protein, human
  • IL6 protein, human
  • Interleukin-18
  • Interleukin-6
  • LRG1 protein, human
  • C-Reactive Protein
  • Ferritins